language_icon
EN
HI

Morepen Laboratories Share price

MOREPENLAB

42.22

0.00 (0.00%)
NSE
BSE
Last updated on 27 May, 2026 | 15:59 IST
Today's High

42.80

Today's Low

41.38

52 Week Low

33.05

52 Week High

70.50

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Morepen Laboratories Chart

Morepen Laboratories Share Key Metrics

Volume
74.86 L
Market Cap
2313.46 CR
LTQ@LTP
407@42.22
ATP
42
Var Margin
22.54 %
Circuit Range
33.78-50.66
Delivery %
40.37 %
Value
31.44 CR
ASM/GSM
No
Market Lot
1

Summary

Morepen Laboratories share price is ₹42.22 as of 28 May, 2026. The stock Morepen Laboratories intraday movement has stayed between ₹41.38 and ₹42.80, while on a 52-week basis,Morepen Laboratories price 52 week high is ₹70.50 & its 52 week low is ₹33.05.
In terms of trading activity, Morepen Laboratories has recorded a volume of 7486495 shares, The Morepen Laboratories has a market cap of ₹547953699 CR. The stock’s Average Traded Price (ATP) stands at ₹42.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 407 @ ₹42.22.
Morepen Laboratories operates within a circuit range of ₹33.78 – ₹50.66, with a Value of ₹31.44 CR. The Delivery Percentage for the day is 40.37%. Additionally, Morepen Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Morepen Laboratories Fundamentals

View More
P/E Ratio

24.22

P/B Ratio

1.97

Div. Yield

0.46

Sector P/E

71.44

Sector P/B

3.49

Sec. Div. Yield

0.55

Morepen Laboratories Resistance and Support

Pivot 42.13

Resistance

First Resistance

42.88

Second Resistance

43.55

Third Resistance

44.3

Support

First Support

41.46

Second Support

40.71

Third Support

40.04

Morepen Laboratories Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

35.65%

Mutual Fund

0%

Insurance

0.94%

Foreign Institutional Investors

1.58%

Domestic Institutional Investors

0.32%

Retail

61.5%

Others

0.01%

Total Promoters
MAR '26
35.65%

Morepen Laboratories Corporate Actions

DateAgenda
2026-05-26Audited Results & Final Dividend
2026-05-22Audited Results
2026-02-10Quarterly Results
2025-11-14Quarterly Results
2025-08-06Quarterly Results & Others
2025-05-12Audited Results & Final Dividend
2025-02-06Quarterly Results

Morepen Laboratories News

Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Morepen Laboratories announced strong Q4 FY26 results with net profit climbing 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. The company also initiated commercial execution of its CDMO program and proposed a 10% dividend for FY26.
May 27 2026 08:25:48

Morepen Laboratories Limited

Morepen Laboratories has executed a second addendum to its Business Transfer Agreement (BTA) with subsidiary Morepen Medipath Limited. The 'Appointed Date' for the transfer of the undertaking is now revised to April 1, 2026, primarily due to delays in obtaining necessary statutory licenses and regulatory approvals.
May 26 2026 18:12:24

Morepen Laboratories Limited

Morepen Laboratories' board recommended a final dividend of Rs.0.20 per share for FY26. The record date and AGM date for approval will be intimated later.
May 26 2026 18:01:46

Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Morepen Laboratories' Board approved the second addendum to the Business Transfer Agreement (BTA) with subsidiary Morepen Medipath Limited for the slump sale of its Medical Devices business. The transaction is for Rs.197.10 crore, with the revised appointed date for transfer set to April 1, 2026.
May 26 2026 17:56:35

Morepen Laboratories Ltd - 500288 - Corporate Action-Board approves Dividend

Morepen Laboratories Board recommended a final dividend of ₹0.20 per equity share for the financial year ended March 31, 2026. This is subject to shareholder approval at the upcoming Annual General Meeting.
May 26 2026 17:53:34

Morepen Laboratories Ltd - 500288 - Board Meeting Outcome for Board Meeting Outcome For Q4 And FY26 Results

Morepen Laboratories board approved audited consolidated financial results for Q4 FY26, reporting a net profit of ₹15.70 crores. A final dividend of ₹0.20 per equity share was recommended for FY26.
May 26 2026 17:36:47

Morepen Laboratories Limited

Morepen Labs' board meeting, originally on May 22, 2026, has been rescheduled to May 26, 2026. The agenda includes considering audited annual financial results for FY26 and a final dividend.
May 21 2026 19:47:55

Morepen Laboratories Ltd - 500288 - Update on board meeting

Morepen Laboratories' board meeting has been rescheduled to May 26, 2026. The board will consider and approve the audited standalone and consolidated financial results for Q4 and the full financial year ended March 31, 2026, and may recommend a final dividend.
May 21 2026 19:38:02

Morepen Laboratories Limited

Morepen Laboratories transferred 1.62 lakh equity shares of its subsidiary Morepen Medipath Limited (MML) to Mr. Anubhav Suri, Head - Medical Devices Business. This strategic move aims to align Mr. Suri's interests with MML's long-term growth and ensures continuity of leadership, while MML remains a 51% owned subsidiary.
May 20 2026 19:17:47

Morepen Laboratories Limited

Morepen Labs approved the transfer of 1.62 lakh equity shares of its subsidiary Morepen Medipath Ltd to Mr. Anubhav Suri. This strategic move reduces Morepen's stake from 60% to 51% in MML, aiming to align the Head - Medical Device Business's interests with MML's growth while retaining MML as a consolidated subsidiary.
May 20 2026 19:13:01
Read More

Morepen Laboratories Management

NamePosition
Sushil SuriChairman & Managing Director
Sanjay SuriWhole Time Director
View More

Morepen Laboratories FAQs

The Buying Price of Morepen Laboratories share is 42.22 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Morepen Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Morepen Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Morepen Laboratories shares is 24.22. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Morepen Laboratories shares is 1.97. Useful to assess the stock's value relative to its book value.

To assess Morepen Laboratories’s valuation compare Sector P/E, P/B which are 71.44 & 3.49 with sector averages, along with growth rates and financial metrics.

The Market Cap of Morepen Laboratories is 2313.46 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Morepen Laboratories share price is 70.50 & 33.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Morepen Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost